Drawing for HEMATRAK

USPTO serial 73005983

HEMATRAK

Reviewed by CopyMark Law Group

Reg. 1029205Status 900
Filing date
Status date
Registration date
Jan 6, 1976
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEMATRAK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrea S. Fuelleman

Andrea S. Fuelleman Neal, Gerber & Eisenberg LLPTwo North LaSalle Street, Suite 1700Chicago, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009BLOOD CELL ANALYZER AND COUNTEREXPIREDOct 15, 1973

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Aug 30, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 14, 1996EXRGEXPIRED SEC. 9—
Mar 2, 1982C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—

Frequently asked questions

Related guidance